A tendon injury treatment firm that has licensed technology developed at the Mayo Clinic has raised $11.8 million through a PIPE (private investment in a public entity) transaction. Tenex Health is a California company that has developed the FAST (Focused Aspiration of Soft Tissue) procedure for percutaneous removal of tissue that can help restore the normal functioning of tendons and soft tissue. Last February, Tenex announced the FDA clearance of its portable device used in conjunction with the FAST procedure that allowed soft tissue removal in the elbow, knee, ankle, foot, and shoulder.
MedCity News, by Arundhati Parmar, 02/06/2012
Additional coverage: Minneapolis/St.Paul Business Journal
Tags: FAST, FDA, Focused Aspiration of Soft Tissue, PIPE, private investment in a public entity, soft tissue, tendons, Tenex Health, Uncategorized